• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Chemokines in cardiac allografts promote graft rejection in mice

bySarah StapletonandChaz Carrier
July 16, 2014
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Cardiac allografts without the CCL2 chemokine demonstrated increased graft survival time when compared with wild type (WT) allografts in a mouse model of antibody-mediated rejection (AMR). 

2. Markers of AMR including infiltration of classically activated host macrophages, donor-reactive antibody response, and intragraft inflammatory chemokine and cytokine expression were decreased in the CCL2negative (-/-) allograft mice. 

Evidence Rating Level: 2 (Good)

Study Rundown: The host immune response that drives rejection of a transplanted donor tissue is a concerted effort of both cell and antibody-mediated processes. While studies have begun to investigate the function of particular immune cells in the cellular rejection of grafts, few have explored the role of these cells in antibody-mediated rejection (AMR). Employing a mouse model of AMR that reduces T cell activity, researchers have now investigated the role of CCL2 (or MCP-1), a known macrophage chemoattractant, in cardiac allograft rejection. They found that, while both graft types failed, CCL2(-/-) allografts experienced longer survival times than wild type (WT) allografts in the model of AMR. No survival difference was found in the cellular-rejection model, in which host T cell activity was not hindered. At the time of WT graft rejection, mice with CCL2(-/-) grafts exhibited reduced levels of multiple markers of AMR, including host immune cell infiltration into the graft, donor-reactive antibody responses and intragraft expression of inflammatory-associated chemokines and cytokines such as TNFα and IL-1β. Interestingly, at the time of CCL2(-/-) graft failure many of the reduced AMR markers had increased to the levels of WT at failure. Studies have suggested that transplant rejection may be governed by different responses in humans and mice. Consequently, the results of this study must be confirmed in human studies.

Click to read the study in American Journal of Transplantation

Relevant Reading: Macrophages Contribute to Cellular But Not Humoral Mechanisms of Acute Rejection in Rat Renal Allografts

RELATED REPORTS

Transcatheter closure of patent ductus arteriosus demonstrates similar outcomes compared to surgical repair

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

Intravenous amino acids decrease acute kidney injury following cardiac surgery

In-Depth [animal study]: This study employed B6.CCR5-/-/CD8-/- mice as cardiac allograft recipients to model AMR. As a comparative model of cellular-mediated rejection (CMR), WT C57BL/6 recipient mice were used. Cardiac allografts were harvested from WT A/J or CCL2-deficient A/J donors and grafted to host mice by heterotopic intra-abdominal cardiac transplantation. Grafts not included in survival analysis were removed at day 7 post transplantation and analyzed via flow cytometry for infiltrating neutrophils, macrophages, dendritic cells and T cells as well as donor-specific antibodies. RNA purification and reverse transcription polymerase chain reaction were use to evaluate macrophage activation phenotype. Kaplan-Meier analysis was used to predict survival events and log-rank testing was used for comparisons. Significance (p < 0.01) was determined by Mann-Whitney nonparametric testing. Allograft median survival time (MST) in the AMR model was significantly improved in CCL2(-/-) grafts (MST: Day 10) when compared to WT grafts (MST: Day 8). No significant difference in mean survival was found between graft types in the CMR model. CCL2(-/-)graft recipients demonstrated lower numbers of infiltrating classically activated macrophages, neutrophils, and CD4 T cells at day 7. Donor-specific antibodies and intragraft expression of TNFα and IL-1β were decreased in CCL2(-/-) grafts at day 7 in the AMR model, though this significant reduction was lost by time of CCL2(-/-) graft failure.

More from this author: Modulating lymphocyte populations decreases graft rejection in mice,Adding Evolocumab to statin therapy further decreases LDL-C levels,Genetic variant linked to poor patient survival following lung transplantation, Genetic variations may predict outcomes for colorectal cancer patients, Neuroendocrine tumor marker pancreastatin may be predictive of survival 

2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

[cite source=’doi’]10.1021/jf904082b[/cite]

Tags: Cardiac surgery
Previous Post

Hypothermia in perinatal asphyxia encephalopathy preserves IQ

Next Post

Antibiotic GBS prophylaxis linked to decreased early-onset neonatal infection [Pediatrics Classics Series]

RelatedReports

Colchicine may lower the risk of cardiovascular events in patients with coronary disease
Cardiology

Transcatheter closure of patent ductus arteriosus demonstrates similar outcomes compared to surgical repair

June 13, 2025
Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease
Cardiology

Catheter-guided aortic valve replacement and angioplasty has favorable outcomes compared to surgical intervention

February 11, 2025
Cardiology

Intravenous amino acids decrease acute kidney injury following cardiac surgery

September 30, 2024
Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial
Cardiology

Sex related differences associated with atrial fibrillation post cardiac surgery

August 28, 2024
Next Post
Classics Series, Landmark Trials in Medicine

Antibiotic GBS prophylaxis linked to decreased early-onset neonatal infection [Pediatrics Classics Series]

New dengue fever vaccine effective in phase 3 trial

New dengue fever vaccine effective in phase 3 trial

Women electing abortion more likely to be victims of domestic violence

Racial disparities persist in obstetric care

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravaginal conjugated oestrogen does not improve continuation rate of ring pessary use
  • Artificial intelligence based clinical decision systems are safe and effective for diabetes management
  • Epic Launchpad propels generative-AI into everyday hospital routines
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.